Items tagged with Treatment

Global Phase 3 “STAND” trial launched to test new tuberculosis drug regimen PaMZ to shorten, improve treatment (post with simple image)

STAND trial will take place in approximately 50 study sites in Africa, Asia, Caribbean, Eastern Europe, and Latin America; Results published in The Lancet show PaMZ’s promise to dramatically shorten and simplify therapy for patients with drug-resistant TB; Regimen could improve treatment for those with drug-sensitive TB and those with HIV co-infection.

The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)

Phase 3 STAND trial launched to advance PaMZ through final stage of testing.

Leading medical organizations team up to bring new TB treatments to those in need (post with simple image)

International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).

MSF issue brief: Ready, set, slow down (post with simple image)

New and promising DR-TB drugs are grabbing headlines but not reaching patients.

Treating drug-sensitive TB in India: Implementation of daily therapy with fixed-dose combinations (post with simple image)

A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives (post with simple image)

This review outlines challenges in accessing drugs encountered from the perspective of clinicians, patients and affected communities, and offers potential solutions.

ECDC: Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA (post with simple image)

​This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens. 

The bedaquiline donation program started on April 1 (post with simple image)

A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.

Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)

The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.

Team lands NIH funds to examine tuberculosis and metabolism (post with simple image)

A team from Colorado State University will play a crucial role in a new project funded by the National Institutes of Health to examine factors that make people susceptible to the bacterium that causes tuberculosis and to discover new treatment strategies.

Page 48 of 54 · Total posts: 0

←First 47 48 49 Last→